Core Laboratories (CLB) Income Statement
Core Laboratories Income Statement
Last quarter (Q3 2026), Core Laboratories's total revenue was $132.08M, a decrease of 1.82% from the same quarter last year. In Q3, Core Laboratories's net income was $5.44M. See Core Laboratories’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 526.52M | $ 523.85M | $ 509.79M | $ 489.74M | $ 470.25M | |
| $ 94.28M | $ 88.37M | $ 94.05M | $ 78.92M | $ 83.84M | |
| $ 43.80M | $ 29.82M | $ 39.41M | $ 37.40M | $ 38.58M | |
| Depreciation and Amortization | $ 14.65M | $ 14.95M | $ 15.78M | $ 17.16M | $ 18.52M |
| $ 71.12M | $ 73.51M | $ 70.42M | $ 58.69M | $ 63.78M | |
| $ 50.49M | $ 58.56M | $ 54.64M | $ 41.52M | $ 45.26M | |
| $ -4.59M | $ -12.37M | $ -13.43M | $ -11.57M | $ -9.15M | |
| $ 45.90M | $ 46.19M | $ 41.21M | $ 29.95M | $ 36.11M | |
| $ 29.67M | $ 31.40M | $ 36.67M | $ 19.45M | $ 19.73M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.68 | $ 0.67 | $ 0.79 | $ 0.42 | $ 0.43 |
| Diluted EPS | $ 0.68 | $ 0.66 | $ 0.77 | $ 0.42 | $ 0.42 |
| Weighted Average Shares Outstanding | 46.50M | 46.90M | 46.68M | 46.33M | 46.01M |
| Weighted Average Shares Outstanding (Diluted) | 46.50M | 47.69M | 47.52M | 46.81M | 46.69M |
Currency in USD
